Natural Compounds in Disease Treatment

Работ: 31

Ciwujianoside C1 (Yemuoside YM14)
Shakhnoza S. Azimova
ГлаваNatural product bioactivities and synthesis2012Цитирований: 1
ABI
Ciwujianoside C4
Shakhnoza S. Azimova
ГлаваNatural product bioactivities and synthesis2012Цитирований: 0
ABI
6α-Tigloyloxy-3β-hydroxy-1,10-epoxy-4E-humulene (Chatferin)
Shakhnoza S. Azimova, Ashraf I. Saidkhodzhaev
ГлаваPhytochemistry and Bioactive Compounds2012Цитирований: 0
ABI
Gymnemoside-f
Shakhnoza S. Azimova
ГлаваPhytochemistry and Bioactive Compounds2012Цитирований: 0
ABI
Ciwujianoside D2
Shakhnoza S. Azimova
ГлаваPhytochemistry and Bioactive Compounds2012Цитирований: 0
ABI
Ciwujianoside C2
Shakhnoza S. Azimova
ГлаваNatural Compounds in Disease Treatment2012Цитирований: 0
ABI
Xanthorhiza simplicissima Marsh.
Shakhnoza S. Azimova, Anna I. Glushenkova
ГлаваPhytochemistry and Bioactive Compounds2012Цитирований: 0
ABI
Ciwujianoside E
Shakhnoza S. Azimova
ГлаваNatural Compounds in Disease Treatment2012Цитирований: 0
ABI
Ciwujianoside C3
Shakhnoza S. Azimova
ГлаваNatural Compounds in Disease Treatment2012Цитирований: 0
ABI
Pseudoginsenoside RS1
Shakhnoza S. Azimova
ГлаваNatural product bioactivities and synthesis2012Цитирований: 0
ABI
Rhododendron farrerae Tate ex Sweet
Shakhnoza S. Azimova, Anna I. Glushenkova
ГлаваBioactive Natural Diterpenoids Research2012Цитирований: 0
ABI
Gymnemoside-b
Shakhnoza S. Azimova
ГлаваPhytochemistry and Bioactive Compounds2012Цитирований: 0
ABI
Thymus cariensis
Shakhnoza S. Azimova, Anna I. Glushenkova
ГлаваNatural Compounds in Disease Treatment2012Цитирований: 0
ABI
Pseudoginsenoside RC1
Shakhnoza S. Azimova
ГлаваPharmacological Effects of Natural Compounds2012Цитирований: 0
ABI
Scutellaprostin-A
Shakhnoza S. Azimova, Валентина И. Виноградова
ГлаваFlavonoids in Medical Research2012Цитирований: 0
ABI
Efficacy of Pharmacopuncture for Treating Children with Physical Disabilities in Uzbekistan
Ismailov N. Zohidjon, Jun-Sang Yu
СтатьяHealthcare and Venom ResearchJournal of pharmacopuncture2013Цитирований: 0
ABI
Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: behavioral psychomotor performance, neurotransmitter level and oxidative-inflammatory burden in brain of rats
Faten Abbas, Mohamed Ahmed Eladl, Mohamed El‐Sherbiny +5
ПрепринтNigella sativa pharmacological applicationsResearch Square2021Цитирований: 0
ABI
Askaridoz kasalligi
Axadov Abdulatif Temirovich., Yermanov Rustam Temirovich.
СтатьяNatural Compounds in Disease TreatmentZenodo (CERN European Organization for Nuclear Research)2023Цитирований: 0
ABI
THE BEGINNING OF ETHNOBOTANICAL STUDY OF ACCLIMATIZED GINKGO BILOBA IN UZBEKISTAN
Ibrokhim Askarov, N. A. Razzakov
СтатьяGinkgo biloba and Cashew ApplicationsQO‘QON UNIVERSITETI XABARNOMASI2024Цитирований: 0
ABI
Targeting the lung tumor microenvironment by phytochemicals and their nanoformulations
Safia Obaidur Rab, Farag M. A. Altalbawy, Muktesh Chandra +8
Обзорная статьяNatural Compounds in Disease TreatmentPathology - Research and Practice2024Цитирований: 0
ABI
FARMAKORESISTENT EPILEPSIYADA XIRURGIK DAVOLASH NATIJALARI
Sheraliyeva N.B Sheraliyeva N.B, Abduvoyitov B.B
СтатьяNatural Compounds in Disease TreatmentZenodo (CERN European Organization for Nuclear Research)2025Цитирований: 0
ABI
FARMAKORESISTENT EPILEPSIYADA XIRURGIK DAVOLASH NATIJALARI
Sheraliyeva N.B Sheraliyeva N.B, Abduvoyitov B.B
СтатьяNatural Compounds in Disease TreatmentZenodo (CERN European Organization for Nuclear Research)2025Цитирований: 0
ABI
FARMAKORESISTENT EPILEPSIYADA XIRURGIK DAVOLASH NATIJALARI
Sheraliyeva N.B, Abduvoyitov B.B
СтатьяNatural Compounds in Disease TreatmentZenodo (CERN European Organization for Nuclear Research)2025Цитирований: 0
ABI
FARMAKORESISTENT EPILEPSIYADA XIRURGIK DAVOLASH NATIJALARI
Sheraliyeva N.B, Abduvoyitov B.B
СтатьяNatural Compounds in Disease TreatmentZenodo (CERN European Organization for Nuclear Research)2025Цитирований: 0
ABI
PLANTAGO O'SIMLIGI ASOSLI YANGI DORI VOSITALARINING SPETSIK FAOLLIGINI O'RGANISH
Turg'unov A.D, Saydaliyeva F.A
СтатьяBioactive Compounds in PlantsZenodo (CERN European Organization for Nuclear Research)2025Цитирований: 0
ABI